Holdaas, H. and Jardine, A. (2012) Chronic kidney disease: do patients with CKD benefit from lipid-lowering therapy? Nature Reviews Nephrology, 8(12), pp. 684-685. (doi: 10.1038/nrneph.2012.240)
Full text not currently available from Enlighten.
Abstract
Patients with chronic kidney disease (CKD) have a greatly increased risk of premature cardiovascular morbidity and mortality.1 The pattern of disease also differs from that in the general population, with a disproportionate increase—particularly in patients with more advanced CKD—in sudden (presumed arrhythmic) death and deaths due to heart failure, rather than atheromatous coronary artery disease (CAD).
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Jardine, Professor Alan |
| Authors: | Holdaas, H., and Jardine, A. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
| Journal Name: | Nature Reviews Nephrology |
| ISSN: | 1759-5061 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details